IGC Pharma (IGC) Earnings Date & Reports

IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer’s disease, period cramps, premenstrual syndrome, and chronic pain... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

IGC is expected to report earnings to fall 33.33% to -1 cents per share on February 05

Q3'26

Est.

$-0.02

Q2'26

Missed

by $0.01

Q1'26

Beat

by $0.01

Q4'25

Beat

by $0.01

Q3'25

Est.

$-0.02

The last earnings report on August 14 showed earnings per share of -2 cents, missing the estimate of -1 cents. With 378.18K shares outstanding, the current market capitalization sits at 28.33M.

View a ticker or compare two or three

IGC

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for IGC